BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10442370)

  • 1. Epirubicin, cyclophosphamide, and UFT plus oral calcium folinate in advanced breast cancer.
    Smith IE
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):82-5. PubMed ID: 10442370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
    Kim YH; Kim BS; Seo JH; Choi CW; Kim JS; Chun HJ; Hyun JH; Kim JS
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):64-8. PubMed ID: 10442365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UFT/oral calcium folinate plus weekly paclitaxel for metastatic breast cancer.
    Lück HJ; Scholz U; Kühnle H; Dethling J
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):74-6. PubMed ID: 10442368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer.
    Gregory RK; Johnston SR; Smith IE; Miles D
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):47-9. PubMed ID: 11098493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uracil/tegafur plus oral calcium folinate in advanced breast cancer.
    Richardet E; Pedraza C; Mickiewicz E; Lerzo G; Bonamasa M; Coppola F; Elli A; Uranga G; Jovtis S; Bruno M; Ventriglia M; Cuevas MA; Alvarez AM; Suarez LA; Fein L
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):96-7. PubMed ID: 10442373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
    Klaassen U; Borquez D; Lang S; Oberhoff C; Harstrick A; Seeber S; Benner S
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):71-3. PubMed ID: 10442367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin and UFT/oral calcium folinate for advanced colorectal carcinoma.
    Hoff PM; Pazdur R
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):48-50. PubMed ID: 10442361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UFT/calcium folinate plus weekly paclitaxel for solid tumors.
    Bokemeyer C; Hartmann JT; Kollmannsberger C; Mayer F; Kanz L
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):106-11. PubMed ID: 10442376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative UFT and calcium folinate and radiotherapy in rectal cancer.
    Hoff PM; Lassere Y; Pazdur R; Janjan N; Crane C; Skibber J
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):129-31. PubMed ID: 10442382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer.
    Smith R; Wickerham DL; Wieand HS; Colangelo L; Mamounas EP
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):44-7. PubMed ID: 10442360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UFT in the treatment of colorectal and breast cancer.
    Sun W; Haller D
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):49-56. PubMed ID: 11219978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UFT plus oral calcium folinate/vinorelbine for advanced breast cancer.
    Fumoleau P; Déporte-Fety R; Kerbrat P; Laguerre B
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):86-90. PubMed ID: 10442371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of uracil/tegafur plus oral calcium folinate on resource utilization.
    Ollendorf D
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):42-3. PubMed ID: 10442359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel, UFT, and calcium folinate in metastatic breast cancer.
    Dickson NR; Nicholson BP; Hande K; Blanke C; Johnson D; Cohen A
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):69-70. PubMed ID: 10442366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UFT plus calcium folinate plus radiotherapy for recurrent rectal cancer.
    Hoffmann W; Schiebe M; Dethling J; Martin C
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):125-6. PubMed ID: 10442380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
    Díáz-Rubio E; Sastre J; Abad A; Navarro M; Aranda E; Carrato A; Gallén M; Marcuello E; Rifá J; Massuti T; Cervantes A; Antón A; Fernández Martos C
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):35-40. PubMed ID: 10442357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UFT and oral calcium folinate as first-line chemotherapy for metastatic gastric cancer.
    Ravaud A; Borner M; Schellens JH; Geoffrois L; Schöffski P; Wanders J; Hanauske AR
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):61-3. PubMed ID: 10442364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
    Hortobagyi GN; Heim W; Hutchins L; Rivera E; Mason B; Booser DJ; Kirshner J
    Cancer; 2010 Mar; 116(6):1440-5. PubMed ID: 20091835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.